Drug intelligence / Profile preview

maduramicin

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Maduramicin is a naturally occurring polyether ionophore antibiotic and antiprotozoal agent used in veterinary medicine, primarily as a prophylactic against coccidiosis in poultry and other livestock. It was first isolated from the actinomycete Actinomadura rubra. Maduramicin acts by forming complexes with monovalent cations (especially potassium), facilitating their transport across protozoal cell membranes. This disrupts ionic gradients, inhibits mitochondrial functions such as substrate oxidation and ATP hydrolysis, increases osmotic pressure within the parasite, and ultimately leads to protozoal cell death. While effective against Eimeria species (the causative agents of coccidiosis), it is highly toxic if misused or ingested by non-target species—including humans—causing cardiac toxicity, skeletal muscle degeneration, rhabdomyolysis, renal failure, and potentially death[1][2][3][5][6]. There is no specific antidote for poisoning.

Brand names
Cygro
Other names
maduramycinmaduramicin ammonium
02

Targets

Protozoal and bacterial cell membrane lipid phase

Beyond the preview

Go deeper on maduramicin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on maduramicin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call